Arteris (NASDAQ:AIP) Major Shareholder Sells 2,756 Shares

February 12, 2026 by InsiderTrades.com

Key Points

CEO sale: On Feb. 9 CEO K. Charles Janac sold 47,244 shares at an average of $15.21 for $718,581, leaving him with 9,351,827 shares (a 0.50% ownership decrease) valued at about $142.24M.
The Feb. 9 trade is part of a string of sizable insider sales since December (including multiple 40k–70k share blocks), a pattern that could pressure investor sentiment.
Business and analyst backdrop: NXP expanded deployment of Arteris system IP in AI-enabled designs—providing commercial validation that could drive revenue—while analysts show mixed views (consensus "Hold" with a median target ≈ $17.50 and several Buy ratings).

Arteris, Inc. (NASDAQ:AIP - Get Free Report) major shareholder Bayview Legacy, Llc sold 2,756 shares of the business's stock in a transaction dated Tuesday, February 10th. The stock was sold at an average price of $15.03, for a total transaction of $41,422.68. Following the completion of the sale, the insider owned 9,349,071 shares in the company, valued at approximately $140,516,537.13. This trade represents a 0.03% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Large shareholders that own 10% or more of a company's shares are required to disclose their sales and purchases with the SEC.

Small Cap, Big Potential: 3 Tech Disruptors You Should Know About

Bayview Legacy, Llc also recently made the following trade(s):

On Monday, February 9th, Bayview Legacy, Llc sold 47,244 shares of Arteris stock. The stock was sold at an average price of $15.21, for a total transaction of $718,581.24.
On Thursday, January 15th, Bayview Legacy, Llc sold 17,884 shares of Arteris stock. The shares were sold at an average price of $17.84, for a total value of $319,050.56.
On Tuesday, January 13th, Bayview Legacy, Llc sold 2,116 shares of Arteris stock. The stock was sold at an average price of $17.79, for a total transaction of $37,643.64.
On Thursday, January 8th, Bayview Legacy, Llc sold 50,000 shares of Arteris stock. The stock was sold at an average price of $16.58, for a total value of $829,000.00.
On Monday, December 8th, Bayview Legacy, Llc sold 70,000 shares of Arteris stock. The shares were sold at an average price of $17.71, for a total value of $1,239,700.00.
On Friday, December 5th, Bayview Legacy, Llc sold 60,000 shares of Arteris stock. The shares were sold at an average price of $17.08, for a total transaction of $1,024,800.00.
On Thursday, December 4th, Bayview Legacy, Llc sold 40,000 shares of Arteris stock. The stock was sold at an average price of $16.46, for a total transaction of $658,400.00.

Arteris Price Performance

Shares of NASDAQ AIP opened at $15.10 on Thursday. The company has a market capitalization of $659.57 million, a P/E ratio of -18.19 and a beta of 1.47. Arteris, Inc. has a one year low of $5.46 and a one year high of $19.85. The business's 50-day moving average price is $16.32 and its two-hundred day moving average price is $13.22.

Institutional Investors Weigh In On Arteris

5 Semiconductor stocks under $10

Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Acuitas Investments LLC acquired a new stake in shares of Arteris in the second quarter valued at approximately $858,000. Worth Venture Partners LLC acquired a new stake in Arteris during the 2nd quarter worth $451,000. Franklin Resources Inc. grew its position in shares of Arteris by 9.6% in the 2nd quarter. Franklin Resources Inc. now owns 1,637,171 shares of the company's stock valued at $15,602,000 after purchasing an additional 142,936 shares during the period. Campbell & CO Investment Adviser LLC bought a new stake in shares of Arteris during the second quarter worth $254,000. Finally, Squarepoint Ops LLC lifted its holdings in shares of Arteris by 143.8% in the second quarter. Squarepoint Ops LLC now owns 120,957 shares of the company's stock valued at $1,153,000 after purchasing an additional 71,340 shares in the last quarter. Institutional investors and hedge funds own 64.36% of the company's stock.

Arteris News Roundup

Here are the key news stories impacting Arteris this week:

Positive Sentiment: NXP Semiconductors expanded its deployment of Arteris system IP (FlexNoC, Ncore, CodaCache) and integration tools across AI‑enabled SoC, NPU and MCU designs — a clear commercial validation that can support revenue growth and positioning in edge AI markets. Arteris Technology Deployed More Broadly by NXP
Positive Sentiment: Institutional inflows and recent analyst coverage remain constructive (several funds added positions; Rosenblatt has a Buy rating and higher price target), which provides ongoing support for upside versus the current price level.
Neutral Sentiment: A Q4 2025 earnings preview was published — the upcoming quarterly report is a near‑term catalyst that could amplify moves if results or guidance diverge from expectations. What to Expect from Arteris Inc (AIP) Q4 2025 Earnings
Neutral Sentiment: Short‑interest data in feeds is inconsistent (entries showing 0 or NaN alongside an earlier ~1.13M shares short as of Jan 30). The noisy reporting makes it hard to read short‑squeeze risk; treat this metric cautiously until exchanges reconcile figures.
Negative Sentiment: Insiders sold shares this week: CEO K. Charles Janac sold 47,244 shares on Feb 9 (avg ~$15.21) and an additional 2,756 shares on Feb 10; major shareholder Bayview Legacy, LLC reported parallel sales. The CEO’s repeated sales over recent months (multi‑month pattern) may damp investor sentiment and add supply pressure. SEC filing: Janac insider sales

Wall Street Analyst Weigh In

Three IPO’s To Buy In December

Several research firms have recently weighed in on AIP. Weiss Ratings reissued a "sell (d-)" rating on shares of Arteris in a research report on Wednesday, January 21st. Jefferies Financial Group raised shares of Arteris to a "hold" rating in a report on Tuesday, October 28th. Rosenblatt Securities restated a "buy" rating and issued a $20.00 price target on shares of Arteris in a research report on Monday, December 15th. Finally, TD Cowen restated a "buy" rating on shares of Arteris in a report on Wednesday, November 5th. Three research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the company presently has a consensus rating of "Hold" and a consensus price target of $17.50.

Check Out Our Latest Report on Arteris

Arteris Company Profile

(Get Free Report)

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company's core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.